Literature DB >> 29685673

Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.

Takuya Ikegawa1, Atsuhiro Masuda2, Arata Sakai1, Hirochika Toyama3, Yoh Zen4, Keitaro Sofue5, Takashi Nakagawa1, Hideyuki Shiomi1, Mamoru Takenaka6, Takashi Kobayashi1, Masaru Yoshida1, Yoshifumi Arisaka7, Yoshihiro Okabe8, Hiromu Kutsumi9, Takumi Fukumoto3, Takeshi Azuma1.   

Abstract

OBJECTIVES: The present study was conducted in order to elucidate the relationship between the number of cyst-existing regions and incidence of pancreatic ductal adenocarcinoma (PDAC) concomitant with intraductal papillary mucinous neoplasm (IPMN), which currently remains unclear.
METHODS: Subjects comprised 141 patients undergoing resection for IPMN (Non-invasive IPMN (IPMN with low-to high-grade dysplasia): N = 94, invasive IPMN: N = 31, and PDAC concomitant with IPMN: N = 16) between November 2000 and February 2017. A logistic regression analysis was performed to assess the relationship between the number of cyst-existing regions (one region/two or more regions) and incidence of PDAC concomitant with IPMN, adjusted by clinical characteristics. Cyst-existing regions were defined by the number of anatomical parts of the pancreas: the head/body/tail of the pancreas.
RESULTS: Multiple cyst-existing regions (two or more regions) correlated with the incidence of PDAC concomitant with IPMN (PDAC concomitant with IPMN in one region vs. two or more regions: 3/66 vs. 13/75, multivariable odds ratio [OR] = 4.11, 95% confidence interval [CI] = 1.22 to 18.8, P = 0.02). In contrast, multiple cyst-existing regions did not correlate with the incidence of IPMN (invasive IPMN in one region vs. two or more regions: 13/66 vs. 18/75, OR = 1.19, 95% CI = 0.52 to 2.76, P = 0.67).
CONCLUSIONS: Multifocal cysts correlated with the incidence of PDAC concomitant with IPMN, and may be a high-risk factor for PDAC concomitant with IPMN.
Copyright © 2018 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intraductal papillary mucinous neoplasm; Number of cyst-existing regions; Pancreatic cancer

Mesh:

Year:  2018        PMID: 29685673     DOI: 10.1016/j.pan.2018.04.005

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  5 in total

1.  Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.

Authors:  Koichiro Mandai; Koji Uno; Kojiro Nakase; Takuji Kawamura; Kenjiro Yasuda
Journal:  J Med Ultrason (2001)       Date:  2019-05-08       Impact factor: 1.314

Review 2.  Diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Pablo Cortegoso Valdivia; Claudia Chialà; Ludovica Venezia; Federica Gaiani; Gioacchino Leandro; Francesco Di Mario; Gian Luigi De' Angelis
Journal:  Acta Biomed       Date:  2018-12-17

3.  Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm.

Authors:  Satoshi Kawakami; Mitsuharu Fukasawa; Tatsuya Shimizu; Shintaro Ichikawa; Tadashi Sato; Shinichi Takano; Makoto Kadokura; Hiroko Shindo; Ei Takahashi; Sumio Hirose; Yoshimitsu Fukasawa; Hiroshi Hayakawa; Yasuhiro Nakayama; Tatsuya Yamaguchi; Taisuke Inoue; Shinya Maekawa; Hiromichi Kawaida; Utaroh Motosugi; Hiroshi Onishi; Nobuyuki Enomoto
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Partial pancreatic tail preserving subtotal pancreatectomy for pancreatic cancer: Improving glycemic control and quality of life without compromising oncological outcomes.

Authors:  Li You; Lie Yao; Yi-Shen Mao; Cai-Feng Zou; Chen Jin; De-Liang Fu
Journal:  World J Gastrointest Surg       Date:  2020-12-27

5.  Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study.

Authors:  Hanna Seppänen; Tiina E Lehtimäki; Katarina Johansson; Harri Mustonen
Journal:  BMC Gastroenterol       Date:  2022-08-21       Impact factor: 2.847

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.